2 dirt-cheap growth stocks to consider in November

P/E ratios under 13 and strong growth prospects have these under-the-radar stocks on my watchlist.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

After growing earnings by double-digits in each of the last four years, shares of specialist manufacturer Carclo (LSE: CAR) trade at only 10.8 times forward earnings, which has put the firm on my watch list.

The company is fairly diversified with three main divisions: technical moulds for the medical devices industry that brought in £88m in the year to March, making exterior lights for supercars that accounted for £43m in sales, and an aircraft components division that grossed £7m.

Each of these end markets has performed very well in recent years and increased volumes have improved operational gearing, leading to the firm’s operating margins increasing annually from 5.39% in 2013 to 8.3% in fiscal 2017.

However, it’s not all roses and butterflies for Carclo as the UK’s decision to exit the EU has thrown up significant roadblocks for the firm. Brexit wreaked havoc on the bond markets and led to a sharp fall in the bond yields it used to discount its pension obligations. Because of this, its net pension liabilities rose from £18.9m to £27m year-on-year in 2017, which wiped out the firm’s excess cash position, increased leverage and led it to cancel its dividend for the year.

But even with that in mind, Carclo was never a huge income stock and analysts have pencilled in earnings increases of 5% and 20% for the next two years respectively as global GDP growth remains high, stoking demand for each of its end markets. Economic tailwinds and a history of making smart bolt-on acquisitions makes hitting these forecasts entirely reasonable. And with a very attractive valuation, I’ll be digging into Carclo some more in November.

Scalding hot growth on tap? 

Another cheap growth stock on my radar is relatively new IPO Strix Group (LSE: KETL). The company designs and manufactures safety devices for kettles and other water heating devices. The group is the leader for such devices in regulated markets such as the US, UK and Europe with market share of around 60% at the time of its IPO.

This strong position and its patent-protected devices give it significant pricing power that management has used to attain operating margins of 27% in the year to December 2016. In the same year, sales grew 10% as it introduced new products and the global kettle market grew

Looking forward, the group sees good potential to increase its share of non-regulated markets, where it currently supplies roughly 18% of all kettles and in China, where its market share is around 50%. Strix is accomplishing this by developing new devices that offer both the cost savings its OEM customers require and introducing higher safety levels than fellow competitors can offer.

The group can accomplish this as it owns and operates its own manufacturing facilities. One on the Isle of Man focuses on more precision parts, while its Chinese operations focus on volume. With solid growth and income potential and a reasonable valuation of 12.5 times forward earnings, I’ll be keeping an eye on Strix Group in the coming months.

Ian Pierce has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Close-up of British bank notes
Investing Articles

£20,000 for a Stocks and Shares ISA? Here’s how to try and turn it into a monthly passive income of £493

Hundreds of pounds in passive income a month from a £20k Stocks and Shares ISA? Here's how that might work…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

£5,000 put into Nvidia stock last Christmas is already worth this much!

A year ago, Nvidia stock was already riding high -- but it's gained value since. Our writer explores why and…

Read more »

Investing Articles

Are Tesco shares easy money heading into 2026?

The supermarket industry is known for low margins and intense competition. But analysts are bullish on Tesco shares – and…

Read more »

Smiling black woman showing e-ticket on smartphone to white male attendant at airport
Investing Articles

Can this airline stock beat the FTSE 100 again in 2026?

After outperforming the FTSE 100 in 2025, International Consolidated Airlines Group has a promising plan to make its business more…

Read more »

Investing Articles

1 Stocks and Shares ISA mistake that will make me a better investor in 2026

All investors make mistakes. The best ones learn from them. That’s Stephen Wright’s plan to maximise returns from his Stocks…

Read more »

Portrait Of Senior Couple Climbing Hill On Hike Through Countryside In Lake District UK Together
Investing Articles

I asked ChatGPT if £20,000 would work harder in an ISA or SIPP in 2026 and it said…

Investors have two tax-efficient ways to build wealth, either in a Stocks and Shares ISA or SIPP. Harvey Jones asked…

Read more »

Investing Articles

How much would I need invested in an ISA to earn £2,417 a month in passive income?

This writer runs the numbers to see what it takes in an ISA to reach £2,417 a month in passive…

Read more »

Investing Articles

Rolls-Royce shares or Melrose Industries: Which one is better value for 2026?

Rolls-Royce shares surged in 2025, surpassing most expectations. Dr James Fox considers whether it offers better value than peer Melrose.

Read more »